Zhengye Biotechnology Holding Ltd. (ZYBT) Ratios

21 Followers

Zhengye Biotechnology Holding Ltd. Ratios

See a summary of ZYBT’s cash flow.

Ratios	Dec 25	Jun 25	Dec 23	Dec 22
Liquidity Ratios
Current Ratio	―	1.14	1.31	1.37	1.41
Quick Ratio	―	0.82	0.88	0.98	1.04
Cash Ratio	―	0.42	0.14	0.10	0.06
Solvency Ratio	―	-0.34	0.25	0.34	0.40
Operating Cash Flow Ratio	―	0.11	0.30	0.32	0.11
Short-Term Operating Cash Flow Coverage	―	0.20	0.50	0.60	0.32
Net Current Asset Value	¥ ―	¥ 7.66M	¥ 36.86M	¥ 44.98M	¥ 51.50M
Leverage Ratios
Debt-to-Assets Ratio	―	0.17	0.18	0.18	0.12
Debt-to-Equity Ratio	―	0.30	0.30	0.33	0.22
Debt-to-Capital Ratio	―	0.23	0.23	0.25	0.18
Long-Term Debt-to-Capital Ratio	―	0.03	0.02	0.04	0.03
Financial Leverage Ratio	―	1.75	1.74	1.83	1.75
Debt Service Coverage Ratio	―	-0.77	0.49	0.78	1.34
Interest Coverage Ratio	―	-20.07	4.07	10.17	23.19
Debt to Market Cap	―	0.00	0.05	0.00	0.00
Interest Debt Per Share	―	0.00	1.92	0.00	0.00
Net Debt to EBITDA	―	-0.58	1.59	1.04	0.64
Profitability Margins
Gross Profit Margin	―	20.51%	48.99%	61.35%	58.98%
EBIT Margin	―	-58.84%	9.89%	22.77%	25.65%
EBITDA Margin	―	-36.54%	22.86%	34.06%	32.87%
Operating Profit Margin	―	-58.66%	8.82%	21.25%	25.29%
Pretax Profit Margin	―	-61.77%	7.72%	20.68%	24.56%
Net Profit Margin	―	-59.97%	6.07%	14.86%	17.96%
Continuous Operations Profit Margin	―	-71.30%	7.23%	17.72%	21.42%
Net Income Per EBT	―	97.09%	78.58%	71.88%	73.12%
EBT Per EBIT	―	105.30%	87.56%	97.28%	97.08%
Return on Assets (ROA)	―	-15.99%	2.29%	6.29%	8.99%
Return on Equity (ROE)	―	-27.93%	3.98%	11.53%	15.76%
Return on Capital Employed (ROCE)	―	-21.60%	4.60%	12.87%	17.92%
Return on Invested Capital (ROIC)	―	-17.87%	3.50%	8.98%	13.59%
Return on Tangible Assets	―	-18.28%	2.40%	6.50%	9.34%
Earnings Yield	―	0.00%	0.68%	0.00%	0.00%
Efficiency Ratios
Receivables Turnover	―	6.29	2.11	2.13	1.94
Payables Turnover	―	2.10	2.21	1.79	1.35
Inventory Turnover	―	2.36	1.63	1.40	1.93
Fixed Asset Turnover	―	0.49	0.73	0.78	0.92
Asset Turnover	―	0.27	0.38	0.42	0.50
Working Capital Turnover Ratio	―	3.97	3.84	3.60	5.13
Cash Conversion Cycle	―	38.87	231.97	227.86	106.72
Days of Sales Outstanding	―	57.98	173.37	171.46	188.27
Days of Inventory Outstanding	―	154.56	223.54	260.15	189.51
Days of Payables Outstanding	―	173.67	164.95	203.75	271.06
Operating Cycle	―	212.54	396.92	431.61	377.78
Cash Flow Ratios
Operating Cash Flow Per Share	―	0.00	0.87	0.00	0.00
Free Cash Flow Per Share	―	0.00	0.28	0.00	0.00
CapEx Per Share	―	0.00	0.59	0.00	0.00
Free Cash Flow to Operating Cash Flow	―	0.05	0.32	0.76	-0.58
Dividend Paid and CapEx Coverage Ratio	―	1.06	0.94	0.94	0.36
Capital Expenditure Coverage Ratio	―	1.06	1.48	4.15	0.63
Operating Cash Flow Coverage Ratio	―	0.18	0.47	0.54	0.27
Operating Cash Flow to Sales Ratio	―	0.11	0.22	0.23	0.07
Free Cash Flow Yield	―	0.00%	0.79%	0.00%	0.00%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	―	0.00	147.92	0.00	0.00
Price-to-Sales (P/S) Ratio	―	0.00	8.98	0.00	0.00
Price-to-Book (P/B) Ratio	―	0.00	5.89	0.00	0.00
Price-to-Free Cash Flow (P/FCF) Ratio	―	0.00	126.05	0.00	0.00
Price-to-Operating Cash Flow Ratio	―	0.00	40.76	0.00	0.00
Price-to-Earnings Growth (PEG) Ratio	―	0.00	-2.27	0.00	0.00
Price-to-Fair Value	―	0.00	5.89	0.00	0.00
Enterprise Value Multiple	―	-0.58	40.87	1.04	0.64
Enterprise Value	―	24.75M	1.74B	74.78M	55.13M
EV to EBITDA	―	-0.58	40.87	1.04	0.64
EV to Sales	―	0.21	9.34	0.35	0.21
EV to Free Cash Flow	―	35.21	131.16	2.04	-5.52
EV to Operating Cash Flow	―	1.86	42.41	1.55	3.18
Tangible Book Value Per Share	―	0.00	6.99	0.00	0.00
Shareholders’ Equity Per Share	―	0.00	6.02	0.00	0.00
Tax and Other Ratios
Effective Tax Rate	―	-0.15	0.06	0.14	0.13
Revenue Per Share	―	0.00	3.95	0.00	0.00
Net Income Per Share	―	0.00	0.24	0.00	0.00
Tax Burden	―	0.97	0.79	0.72	0.73
Interest Burden	―	1.05	0.78	0.91	0.96
Research & Development to Revenue	―	0.15	0.07	0.06	0.05
SG&A to Revenue	―	0.64	0.34	0.12	0.11
Stock-Based Compensation to Revenue	―	0.00	0.00	0.00	0.00
Income Quality	―	-0.16	3.05	1.28	0.31

Currency in CNY